• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前血清睾酮作为前列腺外侵犯和生化复发预测指标的效用

Usefulness of preoperative serum testosterone as a predictor of extraprostatic extension and biochemical recurrence.

作者信息

Kim Hyoung Jong, Kim Byung Hoon, Park Chol Hee, Kim Chun Il

机构信息

Department of Urology, Keimyung University School of Medicine, Daegu, Korea.

出版信息

Korean J Urol. 2012 Jan;53(1):9-13. doi: 10.4111/kju.2012.53.1.9. Epub 2012 Jan 25.

DOI:10.4111/kju.2012.53.1.9
PMID:22323967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3272561/
Abstract

PURPOSE

A great variety of studies on preoperative serum testosterone as a predictor of progression of prostate cancer have been reported recently. The purpose of this study was to investigate the relationship of preoperative serum testosterone levels in patients who underwent radical prostatectomy with prognostic factors.

MATERIALS AND METHODS

Clinical data were collected from 60 patients who underwent radical prostatectomy. The 60 cases were divided into 2 groups according to their preoperative serum testosterone levels: group 1 (n=21), <3 ng/ml; group 2 (n=39), ≥3 ng/ml. The groups were compared according to prog-ression factors. Multivariate logistic regression analysis was performed to determine the correlation between biochemical recurrence and each variable.

RESULTS

The incidence of extraprostatic invasions was significantly higher in group 1 with 13 cases in group 1 (61.9%) and 11 cases in group 2 (28.2%) (p=0.011). The incidence of biochemical recurrence was also significantly higher in group 1 with 5 cases in group 1 (23.8%) and 2 cases in group 2 (5.1%) (p=0.032). A low serum testosterone level (≤3 ng/ml) was associated with an increased risk of biochemical recurrence (odds ratio [OR], 13.64; 95% confidence interval [CI], 1.66 to 2.43; p=0.015) and an increased risk of extraprostatic invasions (OR, 4.96; 95% CI, 1.41 to 17.38; p=0.012).

CONCLUSIONS

The incidence rates of extraprostatic invasions and biochemical recurrence were significantly higher in the group with preoperative average serum testosterone of less than 3 ng/ml. Therefore, these results suggest that preoperative average serum testosterone will be useful in predicting postoperative prostate cancer progression.

摘要

目的

近期已有大量关于术前血清睾酮作为前列腺癌进展预测指标的研究报道。本研究旨在探讨接受根治性前列腺切除术患者的术前血清睾酮水平与预后因素之间的关系。

材料与方法

收集60例行根治性前列腺切除术患者的临床资料。根据术前血清睾酮水平将60例患者分为2组:第1组(n = 21),<3 ng/ml;第2组(n = 39),≥3 ng/ml。根据进展因素对两组进行比较。进行多因素逻辑回归分析以确定生化复发与各变量之间的相关性。

结果

第1组前列腺外侵犯的发生率显著更高,第1组有13例(61.9%),第2组有11例(28.2%)(p = 0.011)。第1组生化复发的发生率也显著更高,第1组有5例(23.8%),第2组有2例(5.1%)(p = 0.032)。低血清睾酮水平(≤3 ng/ml)与生化复发风险增加(比值比[OR],13.64;95%置信区间[CI],1.66至2.43;p = 0.015)及前列腺外侵犯风险增加(OR,4.96;95% CI,1.41至17.38;p = 0.012)相关。

结论

术前平均血清睾酮低于3 ng/ml组的前列腺外侵犯和生化复发发生率显著更高。因此,这些结果表明术前平均血清睾酮对预测前列腺癌术后进展有帮助。

相似文献

1
Usefulness of preoperative serum testosterone as a predictor of extraprostatic extension and biochemical recurrence.术前血清睾酮作为前列腺外侵犯和生化复发预测指标的效用
Korean J Urol. 2012 Jan;53(1):9-13. doi: 10.4111/kju.2012.53.1.9. Epub 2012 Jan 25.
2
Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy.治疗前总睾酮水平可预测接受根治性前列腺切除术的局限性前列腺癌患者的病理分期。
J Urol. 2003 May;169(5):1670-5. doi: 10.1097/01.ju.0000062674.43964.d0.
3
Tumor contact length of prostate cancer determined by a three-dimensional method on multiparametric magnetic resonance imaging predicts extraprostatic extension and biochemical recurrence.多参数磁共振成像三维方法测定前列腺癌肿瘤接触长度可预测前列腺外延伸和生化复发。
Int J Urol. 2021 Oct;28(10):1012-1018. doi: 10.1111/iju.14633. Epub 2021 Jul 5.
4
Low testosterone and risk of biochemical recurrence and poorly differentiated prostate cancer at radical prostatectomy.低睾酮水平与根治性前列腺切除术后生化复发及低分化前列腺癌风险
Urology. 2008 Dec;72(6):1240-5. doi: 10.1016/j.urology.2008.06.001. Epub 2008 Aug 9.
5
Influence of focal and diffuse extraprostatic extension and positive surgical margins on biochemical progression following radical prostatectomy.根治性前列腺切除术后局灶性和弥漫性前列腺外延伸及阳性手术切缘对生化进展的影响。
Int Braz J Urol. 2012 Mar-Apr;38(2):175-84. doi: 10.1590/s1677-55382012000200005.
6
Usefulness of the nadir value of serum prostate-specific antigen measured by an ultrasensitive assay as a predictor of biochemical recurrence after radical prostatectomy for clinically localized prostate cancer.通过超敏检测法测得的血清前列腺特异性抗原最低点值作为临床局限性前列腺癌根治性前列腺切除术后生化复发预测指标的实用性。
Urol Int. 2006;76(3):227-31. doi: 10.1159/000091624.
7
Clinical, Pathological and Oncologic Findings of Radical Prostatectomy with Extraprostatic Extension Diagnosed on Preoperative Prostate Biopsy.术前前列腺活检诊断的伴有前列腺外侵犯的根治性前列腺切除术的临床、病理和肿瘤学发现。
J Urol. 2019 May;201(5):937-942. doi: 10.1016/j.juro.2018.10.023.
8
Effect of serum testosterone and percent tumor volume on extra-prostatic extension and biochemical recurrence after laparoscopic radical prostatectomy.血清睾酮和肿瘤体积百分比对腹腔镜根治性前列腺切除术后前列腺外扩展及生化复发的影响。
Asian J Androl. 2016 Jan-Feb;18(1):54-9. doi: 10.4103/1008-682X.154317.
9
Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.微血管密度在预测病理分期为T3期前列腺腺癌复发中的作用。
Urology. 1999 Sep;54(3):479-85. doi: 10.1016/s0090-4295(99)00202-2.
10
Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy.前列腺癌根治术后前列腺外癌患者手术切缘阳性的预后意义。
Cancer. 2002 Sep 15;95(6):1215-9. doi: 10.1002/cncr.10871.

引用本文的文献

1
Hypogonadism and urologic surgeries: a narrative review.性腺功能减退与泌尿外科手术:一篇叙述性综述。
Transl Androl Urol. 2022 Jul;11(7):1045-1062. doi: 10.21037/tau-22-308.
2
Narrative review of Mediterranean diet in Cilento: longevity and potential prevention for prostate cancer.奇伦托地区地中海饮食的叙述性综述:长寿与前列腺癌的潜在预防
Ther Adv Urol. 2021 Jul 22;13:17562872211026404. doi: 10.1177/17562872211026404. eCollection 2021 Jan-Dec.
3
Endogenous and exogenous testosterone and prostate cancer: decreased-, increased- or null-risk?内源性和外源性睾酮与前列腺癌:风险降低、增加还是无风险?
Transl Androl Urol. 2017 Jun;6(3):566-579. doi: 10.21037/tau.2017.05.35.
4
The presence of primary circulating prostate cells is associated with upgrading and upstaging in patients eligible for active surveillance.在适合进行主动监测的患者中,原发性循环前列腺细胞的存在与肿瘤分级升高和分期进展相关。
Ecancermedicalscience. 2017 Jan 10;11:711. doi: 10.3332/ecancer.2017.711. eCollection 2017.
5
Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance.低血清总睾酮水平作为符合主动监测纳入标准的低风险前列腺癌患者分期升级和分级升级的预测指标。
Oncotarget. 2017 Mar 14;8(11):18424-18434. doi: 10.18632/oncotarget.12906.
6
Testosterone Therapy Among Prostate Cancer Survivors.前列腺癌幸存者的睾酮治疗。
Sex Med Rev. 2016 Oct;4(4):376-88. doi: 10.1016/j.sxmr.2016.06.005. Epub 2016 Jul 27.
7
Challenges to treat hypogonadism in prostate cancer patients: implications for endocrinologists, urologists and radiotherapists.前列腺癌患者性腺功能减退治疗面临的挑战:对内分泌科医生、泌尿科医生和放疗科医生的启示
Transl Androl Urol. 2015 Apr;4(2):139-47. doi: 10.3978/j.issn.2223-4683.2015.04.01.
8
Testosterone Replacement Therapy and Prostate Cancer Incidence.睾酮替代疗法与前列腺癌发病率
World J Mens Health. 2015 Dec;33(3):125-9. doi: 10.5534/wjmh.2015.33.3.125. Epub 2015 Dec 23.
9
Preoperative low serum testosterone is associated with high-grade prostate cancer and an increased Gleason score upgrading.术前低血清睾酮与高级别前列腺癌及 Gleason 评分升高相关。
Prostate Cancer Prostatic Dis. 2015 Dec;18(4):382-7. doi: 10.1038/pcan.2015.44. Epub 2015 Oct 6.
10
Effect of serum testosterone and percent tumor volume on extra-prostatic extension and biochemical recurrence after laparoscopic radical prostatectomy.血清睾酮和肿瘤体积百分比对腹腔镜根治性前列腺切除术后前列腺外扩展及生化复发的影响。
Asian J Androl. 2016 Jan-Feb;18(1):54-9. doi: 10.4103/1008-682X.154317.

本文引用的文献

1
Significance of Serum Testosterone for Prostate-Specific Antigen (PSA) Elevation and Prediction of Prostate Cancer in Patients with PSA Above 10 ng/ml.血清睾酮对前列腺特异性抗原(PSA)升高的意义及PSA高于10 ng/ml患者前列腺癌的预测
Korean J Urol. 2010 Dec;51(12):831-5. doi: 10.4111/kju.2010.51.12.831. Epub 2010 Dec 21.
2
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.男性雄激素缺乏综合征的睾酮治疗:内分泌学会临床实践指南。
J Clin Endocrinol Metab. 2010 Jun;95(6):2536-59. doi: 10.1210/jc.2009-2354.
3
Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex.雄激素受体(AR)共调节因子:多种功能汇聚并调节AR转录复合物。
Endocr Rev. 2007 Dec;28(7):778-808. doi: 10.1210/er.2007-0019. Epub 2007 Oct 16.
4
Molecular aspects of hormone-independent prostate cancer.激素非依赖性前列腺癌的分子层面
BJU Int. 2007 Jul;100 Suppl 2:52-5. doi: 10.1111/j.1464-410X.2007.06956.x.
5
Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy.术前血清睾酮水平作为根治性前列腺切除术后治疗失败的独立预测指标。
Eur Urol. 2007 Sep;52(3):696-701. doi: 10.1016/j.eururo.2007.03.052. Epub 2007 Mar 26.
6
Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.睾酮替代疗法对迟发性性腺功能减退男性前列腺组织的影响:一项随机对照试验。
JAMA. 2006 Nov 15;296(19):2351-61. doi: 10.1001/jama.296.19.2351.
7
Testosterone and prostate cancer: an historical perspective on a modern myth.睾酮与前列腺癌:现代神话的历史视角
Eur Urol. 2006 Nov;50(5):935-9. doi: 10.1016/j.eururo.2006.06.034. Epub 2006 Jul 27.
8
Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: hypogonadism represents bad prognosis in prostate cancer.血清睾酮水平低与耻骨后根治性前列腺切除术中手术切缘阳性相关:性腺功能减退提示前列腺癌预后不良。
J Urol. 2005 Dec;174(6):2178-80. doi: 10.1097/01.ju.0000181818.51977.29.
9
Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study.前列腺大小与高级别、晚期前列腺癌风险及根治性前列腺切除术后生化进展:一项检索数据库研究
J Clin Oncol. 2005 Oct 20;23(30):7546-54. doi: 10.1200/JCO.2005.05.525.
10
The prevention of prostate cancer--the dilemma continues.前列腺癌的预防——困境仍在继续。
N Engl J Med. 2003 Jul 17;349(3):297-9. doi: 10.1056/NEJMe038109. Epub 2003 Jun 24.